Furthermore, cognitive impairment is generally considered to start in development, with full-length dystrophin having the highest expression in humans at 2 years (Doorenweerd et al. 2017) and being nonprogressive; however, its evolution from the perinatal stage through adolescence to adulthood has not been studied in detail. This evidence concerns the gene DMD and Cognitive impairment.